Edition: Global  
One News Page
“Probably the fastest-access news portal in the world”
> >

U.S. Food and Drug Administration Expands Approval of Sprycel® (dasatinib) to Include Treatment of Children with Philadelphia Chromosome-Positive Chronic Myeloid Leukemia in Chronic Phase

Business Wire Friday, 10 November 2017 ()
U.S. Food and Drug Administration Expands Approval of Sprycel® (dasatinib) to Include Treatment of Children with Philadelphia Chromosome-Positive Chronic Myeloid Leukemia in Chronic PhasePRINCETON, N.J.--(BUSINESS WIRE)--$BMY #BristolMyers--U.S. Food and Drug Administration Expands Approval of Sprycel® (dasatinib) to Include Treatment of Children
0
shares
Share on
Facebook
Share on
Twitter
Post on 
Reddit
Share by
Email
 

Recent related news

Dynavax's hepatitis B vaccine gets FDA nod on third try, shares up

(Reuters) - Dynavax Technologies Corp's hepatitis B vaccine won the U.S. Food and Drug Administration's approval on the third attempt and Chief Executive Eddie...
Reuters - Health

FDA approves AstraZeneca's asthma drug

(Reuters) - Anglo-Swedish pharmaceutical firm AstraZeneca Plc on Tuesday said the U.S. Food and Drug Administration approved its drug benralizumab, as an add-on...
Reuters - HealthAlso reported by •Proactive InvestorsBusiness Wire

Alnylam Initiates Rolling Submission of New Drug Application (NDA) to U.S. Food and Drug Administration (FDA) for Patisiran for the Treatment of Hereditary ATTR (hATTR) Amyloidosis

Alnylam Initiates Rolling Submission of New Drug Application (NDA) to U.S. Food and Drug Administration (FDA) for Patisiran for the Treatment of Hereditary ATTR (hATTR) Amyloidosis
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, today announced the company has initiated...
Business Wire - Press Releases

Third time's the charm: East Bay drug maker wins FDA approval for hepatitis B vaccine

An easier-to-take vaccine from an East Bay company, which could shift the fight against the surging, deadly hepatitis B virus, won regulatory approval Thursday....
bizjournals - BusinessAlso reported by •Business Wire

Molecular Health and U.S. Food and Drug Administration (FDA) Extend Software Collaboration to Drug Safety Prediction

** *Cambridge, MA, USA* - November 16, 2017 - * * Molecular Health, Inc (MH), a company marketing computational biomedicine tools to support healthcare...
GlobeNewswire - Press Releases

Nexstim gains FDA clearance to commercialise its NBT® system in the US for the treatment of depression

* C ompany announcement, Helsinki, 13 November 2017 at 3 pm * Nexstim Plc (NXTMH:HEX, NXTMS:STO) (" *Nexstim* " or " *Company* "), a medical technology...
GlobeNewswire - Press Releases

FDA OKs new therapy for some hemophilia patients

TRENTON, N.J. (AP) — U.S. regulators have approved the first new treatment in nearly two decades to prevent internal bleeding in certain patients with...
SeattlePI.com - Health

Hikma, Vectura in dispute with FDA over generic Advair

LONDON (Reuters) - Hikma and its partner Vectura are in dispute with the Food and Drug Administration over their plans to launch a generic copy of...
Reuters - Health


You Might Like


Other recent news in Press Releases

Fly the Happiest and Safest Skies THANKSGIVING WeekendNINJA BLENDER - SOLLUME ESTHÉ Distributor G&J Completes Venture Company Certification by Ministry of SMEs and Startups (MSS) in SOUTH KOREA
Alternative Rock Radio Returns to DALLAS with the Launch of ALT 103.7A.M. Best Maintains Under Review With Developing Implications Status for Credit Ratings of Macau LIFE INSURANCE Company Limited
IIoT World Tour Stops in SAN FRANCISCO on December 8Madison Realty Capital Provides $64.0 Million Construction Financing for 200 Kent Avenue Development in Williamsburg, BROOKLYN
Become the Hero in Star Wars™ BATTLEFRONT™ II, Launching Across the Galaxy TodayPampers Helped Celebrate the #LittlestFighters at Connecticut Children’s Medical Center In Honor of WORLD PREMATURITY DAY
EQUITY ALERT: Rosen Law Firm Announces FILING of Securities Class Action Lawsuit Against Acorda Therapeutics, Inc. – ACORYara to acquire Vale Cubatão Fertilizantes complex in BRAZIL

Twitter

pic

Andrew Steele RT @bmsnews: #MEDIA: #FDA approves therapy for pediatric patients with a type of chronic myeloid #leukemia: https://t.co/FTnwedRzBV https:/… 11 hours ago

pic

Privateer Gnome❤ RT @bmsnews: #MEDIA: #FDA approves therapy for pediatric patients with a type of chronic myeloid #leukemia: https://t.co/FTnwedRzBV https:/… 1 day ago

pic

Micheal Shu Balance RT @bmsnews: #MEDIA: #FDA approves therapy for pediatric patients with a type of chronic myeloid #leukemia: https://t.co/FTnwedRzBV https:/… 1 day ago

pic

Pedro Gil RT @bmsnews: This recent #FDA approval may bring new hope for children with Ph+ chronic myeloid leukemia in chronic phase: https://t.co/83F… 3 days ago

pic

Patty Mcdonnell RT @bmsnews: This recent #FDA approval may bring new hope for children with Ph+ chronic myeloid leukemia in chronic phase: https://t.co/83F… 3 days ago

Environmentally friendly: One News Page is hosted on servers powered solely by renewable energy
© 2017 One News Page Ltd. All Rights Reserved.  |  About us  |  Disclaimer  |  Press Room  |  Terms & Conditions  |  Privacy Policy  |  Content Accreditation
 RSS  |  News for my Website  |  Free news search widget  |  Help  |  Contact us  |  DMCA / Content Removal
How are we doing? Send us your feedback  |   LIKE us on Facebook   FOLLOW us on Twitter   FIND us on Google+